MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Association between dihydropyridines and dementia conversion in Parkinson’s disease

    JH. Jung, SH. Jeong, SJ. Chung, HS. Yoo, K. Baik, BS. Ye, SJ. Kim, YH. Sohn, PH. Lee (Busan, Republic of Korea)

    Objective: To investigate the role of antihypertensive drugs, including dihydropyridines, on nigrostriatal dopamine and dementia conversion in Parkinson's disease Background: Several experimental and clinical studies…
  • 2022 International Congress

    Pain reduction in adult patients with limb spasticity following a single incobotulinumtoxinA injection: an analysis of pooled data from phase 2 and 3 studies

    J. Wissel, A. Camões-Barbosa, G. Comes, M. Althaus, A. Scheschonka, D. Simpson (Potsdam, Germany)

    Objective: To assess pain relief in a large cohort of incoA-treated pts with spasticity-associated pain (SAP) using pooled data from mostly placebo-controlled phase 2/3 studies.…
  • 2022 International Congress

    [18F]FDG PET in hyperkinetic movement disorders: a systematic review

    E. Timmers, M. Klamer, R. Marapin, A. Lammertsma, B. de Jong, R. Dierckx, M. Tijssen (Groningen, Netherlands)

    Objective: To give a comprehensive literature overview of alterations in regional cerebral glucose metabolism, measured using [18F]FDG PET, in hyperkinetic movement disorders. In addition, correlations…
  • 2022 International Congress

    Muscarinic M2 cholinergic receptors in cervical dystonia

    P. Kassavetis, M. Hosseini, K. Mente, R. Waugh, E. Shamim, W. Dieckmann, P. Herscovitch, M. Hallett, S. Horovitz (Salt Lake City, USA)

    Objective: To characterize the M2 muscarinic acetylcholine receptor binding in patients with cervical dystonia, measured with non-invasive high-resolution PET, using [18F]FP-TZTP ligand. Background: While antimuscarinic…
  • 2022 International Congress

    Myoclonus in a Large Urban Center: 10 Year Experience

    K. Oh, M. Hamed, H. Sarva, D. Victor (New York, USA)

    Objective: To describe various forms of myoclonus in admitted patients in a 10-year period. Background: Myoclonus consists of brief, shock-like involuntary movements. It may occur…
  • 2022 International Congress

    Defining nomenclature and age cut off for Early Onset Parkinson’s Disease: Recommendations from the Early Onset Parkinson’s Disease Task Force.

    R. Mehanna, K. Smilowska, A. Merola, B. Zhang, B. Post, C. Marras, J. Fleisher, K. Kumar, M. Salari, O. Ross, R. Alcalay, T. Hatano, V. Mcconvey, Y-R. Wu, E-K. Tan, R. Savica (Houston, USA)

    Objective: To define the nomenclature for Early Onset Parkinson Disease (EOPD) / Young Onset Parkinson Disease (YOPD), and the age at onset (AAO) cut off…
  • 2022 International Congress

    To be or not to bupropion: a drug-induced parkinsonism?

    A. Silva, J. Pinto, M. Gago, M. Rodrigues (Braga, Portugal)

    Objective: To draw attention to drug-induced parkinsonism. Background: Although the main causes of parkinsonism are degenerative, there are some reversible causes, including drug-induced parkinsonism. Method:…
  • 2022 International Congress

    Epileptic seizures in patients with parkinsonism: experience of a tertiary centre

    C. Azoia, R. Jesus, A. Costa, A. Velon, P. Guimarães (Vila Real, Portugal)

    Objective: We aim to evaluate seizure frequency in patients with parkinsonism in a tertiary centre. Background: Observational studies suggest that the prevalence of epilepsy in…
  • 2022 International Congress

    Clinical, imaging and genetic profile of patients with NBIA spectrum disorders

    N. Sriram, P. Pal, V. Holla, N. Kamble, J. Saini, R. Yadav, RAJ. Battu, VY. K N, B. Muthusamy, RI. Kumari (Bangalore, India)

    Objective: To describe the clinical, imaging and genetic profile of patients with suspected NBIA disorders Background: NBIA disorders are clinically, radiologically and genetically heterogenous group…
  • 2022 International Congress

    The impact of Parkinson’s disease on multifactorial aspects of attention

    O. Peleg, Z. Ktzir, I. Maidan, D. Levy, A. Mirelman (Tel Aviv, Israel)

    Objective: (1) To characterize the differential effects of PD on the two attentional networks and (2) To examine the ability of attentional measurements differentiate between…
  • « Previous Page
  • 1
  • …
  • 35
  • 36
  • 37
  • 38
  • 39
  • …
  • 153
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley